[1] |
LI Mingying, ZHANG Xiaoxia, SUN Xiaoli, ZHAO Yan, HE Miao, LI Yanling, DUAN Wei, YANG Ou.
Effect of Sugammadex on Recovery of Patients after Laparoscopic Total Pelvic Floor Reconstruction
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 896-901.
|
[2] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[3] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[4] |
YANG Xin, YANG Baochun, YANG Yang, SHAO Huan.
One Case of Multiple Endocrine Adverse Effect Caused by Sintilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 947-949.
|
[5] |
WANG Chunting, CHEN Yafei.
Considerations for Revision of Safety Information in the Post-Marketing Instructions of Chemical Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 776-779.
|
[6] |
ZHU Huijuan, REN Jingtian.
Safety Risks of Human Rabies Immunoglobulin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 786-789.
|
[7] |
LI Qiurong, FU Miaoqing, ZHOU Baishui, LI Cui, XIAO Xiaotong, YU Yuping, DENG Lu.
Mining of Real-World ADR Signals Related to Cefradine for Injection in 268 Cases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 790-793.
|
[8] |
CHEN Yaozhe, ZHAN Yunli, SONG Xingdong, ZHU Manyu, OU Xuemei, LI Chuyun.
48 Cases of Hematological Adverse Reactions Associated with Piperacillin Sodium and Tazobactam Sodium
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 794-798.
|
[9] |
TANG Jiong, ZENG Yuqi.
One Case of Oculomotor Paralysis Caused by Sugemalimab Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 812-814.
|
[10] |
WANG Yuan, LI Ruoning, GUO Zhanli, ZHANG Lei, LI Jiayuan, DONG Ying, SUN Jianjun.
One Case of Extremely Severe Thrombocytopenia Caused by Tirofiban Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 815-818.
|
[11] |
LEI Jianlin, WANG Na, WANG Wenzheng, WANG Yan.
One Case of Phenytoin Intoxication Caused by Compound Phenytoin Sodium Ephedrine Hydrochloride and Theophylline Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 819-822.
|
[12] |
ZHONG Xinru, YANG Deying, GUAN Tangming, CHEN Ju, JIANG Dongbo.
Research Progress in Adverse Reactions Caused by Obinutuzumab in the Treatment of Follicular Lymphoma
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 831-835.
|
[13] |
ZHU Lei, ZHANG Xian, WANG Ruiyan, LI Ying.
Adverse Reactions Reports about Tislelizumab Injection in 447 Cases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 649-653.
|
[14] |
ZHENG Sili, ZHANG Xiaoqing.
133 Cases of Adverse Drug Reactions in Female Patients
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 654-658.
|
[15] |
FU Weiran, ZOU Dongmei, NI Jing, SUN Wanling, GUO Yixian.
Short-Term Efficacy and Safety of Thiotepia-based Conditioning Regimen Combined with Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Primary Central Nervous System Lymphoma
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 664-668.
|